XML 138 R2.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Net sales $ 1,185,424 $ 1,207,815 $ 1,139,447
Cost of sales 926,280 956,710 926,618
Gross margin 259,144 251,105 212,829
Selling, general, and administrative expense 147,164 153,489 144,280
Research and development expense 18,271 15,187 13,981
Goodwill impairment charges 11,560 0 0
Asset impairment charges 2,581 0 0
Restructuring expense 785 5,599 644
Other - net 11,783 15,334 13,893
Operating profit 67,000 61,496 40,031
Other non-operating expense-net 3,431 42,683 1,452
Interest expense - net 1,579 2,471 2,183
Income before income taxes 61,990 16,342 36,396
Income tax expense (benefit) 11,330 (4,504) 24,945
Net income $ 50,660 $ 20,846 $ 11,451
Basic earnings per share:      
Net income per share of common stock (in usd per share) $ 2.49 $ 1.03 $ 0.57
Diluted earnings per share:      
Net income per share of common stock (in usd per share) $ 2.45 $ 1.01 $ 0.56
Weighted-average number of shares of common stock outstanding:      
Basic 20,365 20,212 20,027
Diluted 20,655 20,613 20,415